CN1729003A - 包含骨化三醇和丙酸氯倍他索组合物的药物组合物 - Google Patents

包含骨化三醇和丙酸氯倍他索组合物的药物组合物 Download PDF

Info

Publication number
CN1729003A
CN1729003A CNA2003801067244A CN200380106724A CN1729003A CN 1729003 A CN1729003 A CN 1729003A CN A2003801067244 A CNA2003801067244 A CN A2003801067244A CN 200380106724 A CN200380106724 A CN 200380106724A CN 1729003 A CN1729003 A CN 1729003A
Authority
CN
China
Prior art keywords
calcitriol
clobetasol propionate
compositions
pharmaceutical composition
dermatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2003801067244A
Other languages
English (en)
Chinese (zh)
Inventor
A·若马德
O·鲁瓦耶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GALDEMA AG
Original Assignee
GALDEMA AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GALDEMA AG filed Critical GALDEMA AG
Publication of CN1729003A publication Critical patent/CN1729003A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2003801067244A 2002-12-17 2003-12-11 包含骨化三醇和丙酸氯倍他索组合物的药物组合物 Pending CN1729003A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0216016A FR2848454B1 (fr) 2002-12-17 2002-12-17 Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
FR0216016 2002-12-17

Publications (1)

Publication Number Publication Date
CN1729003A true CN1729003A (zh) 2006-02-01

Family

ID=32338900

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2003801067244A Pending CN1729003A (zh) 2002-12-17 2003-12-11 包含骨化三醇和丙酸氯倍他索组合物的药物组合物

Country Status (4)

Country Link
CN (1) CN1729003A (fr)
AR (1) AR042476A1 (fr)
FR (1) FR2848454B1 (fr)
ZA (1) ZA200505174B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
BRPI0511387A (pt) 2004-06-17 2007-12-04 Galderma Sa composição e seu uso
FR2871693B1 (fr) * 2004-06-17 2006-08-25 Galderma Sa Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
FR2884419B1 (fr) * 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
EP1874320A1 (fr) * 2005-04-19 2008-01-09 Galderma S.A. Composition d'une solution de type filmogene, comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
FR2909284B1 (fr) 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
WO2017037663A1 (fr) 2015-09-02 2017-03-09 Cadila Healthcare Limited Compositions topiques comprenant des corticostéroïdes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
RS52182B (sr) * 1999-04-23 2012-10-31 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Farmaceutski preparat

Also Published As

Publication number Publication date
FR2848454A1 (fr) 2004-06-18
FR2848454B1 (fr) 2007-03-30
ZA200505174B (en) 2006-04-26
AR042476A1 (es) 2005-06-22

Similar Documents

Publication Publication Date Title
US9937134B2 (en) Hyaluronate compositions
US20060009426A1 (en) Pharmaceutical compositions comprising calcitriol and a clobetasol propionate
US20200078330A1 (en) Composition for treating wounds and other dermatological conditions
US20030017207A1 (en) Compositions and methods for treating vulvovaginitis and vaginosis
ZA200505174B (en) Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
CN1968702A (zh) 含有骨化三醇和丙酸氯倍他索的药物组合物在治疗牛皮癣中的用途
EP2723330B1 (fr) Agent de polythérapie contenant des vasoconstricteurs
CN116265017A (zh) 一种包含本维莫德和皮质类固醇的药物组合物
CN1065010A (zh) 甾类化合物的组合物
US11224619B2 (en) Formulations and methods for treatment of inflammatory skin diseases
Imamura et al. Tolvaptan reduces long-term total medical expenses and length of stay in aquaporin-defined responders
HU200693B (en) Process for producing pharmaceutical compositon suitable for treating psoriasis
Stoskopf et al. Pharmaceuticals and formularies
EP4306172A1 (fr) Utilisation d'un composé contenant un hétéroaryle tricyclique
CN1863529A (zh) 用于治疗皮肤病症的包括替美斯丁的局部组合物
EP1854466A1 (fr) Composition pharmaceutique comprenant du calcitriol et du propionate de clobétasol
US20190117634A1 (en) Treatment of Vulvodynia
US20210121431A1 (en) Novel compositions and methods for treating cutaneous ulcers and non-healing cutaneous wounds using nitric oxide-donating prostaglandin f-2 -alpha analogs
WO2024005132A1 (fr) Composition pharmaceutique
CN1850080A (zh) 口服分散体型多潘立酮控释凝胶剂及其制法
WO2024187210A1 (fr) Médicament combiné pour le traitement et la réduction du taux de rechute d'une mycose vaginale
EP4364735A1 (fr) Composition pharmaceutique et son utilisation
EP4103215A1 (fr) Compositions et méthodes de traitement ou de prévention du prurit
CN115137699A (zh) 一种增效防腐的右美托咪定鼻喷剂
CN118477068A (zh) 水飞蓟素在制备过敏性皮炎药物中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20060201

CI01 Publication of corrected invention patent application

Correction item: Rejection of patent application

Correct: Dismiss

False: Reject

Number: 31

Volume: 26

ERR Gazette correction

Free format text: CORRECT: PATENT APPLICATION REJECTION AFTER PUBLICATION; FROM: REJECTION TO: REJECTION OF REVOCATION

AD01 Patent right deemed abandoned

Effective date of abandoning: 20060201

C20 Patent right or utility model deemed to be abandoned or is abandoned